Get the app!
Back to Trades

Gilad Oren

President/CEODirectorCIK 0001929300

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Gilad Oren, President/CEO, Director, accounts for 1 disclosed filing worth $61.7K, all concentrated in Aprea Therapeutics, Inc. (APRE), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Mar 16APRE
Aprea Therapeutics, Inc.
Gilad OrenPresident/CEO, DirectorGrant$61.7K

1 filing